Immunotherapy with oral, heat-killed, Mycobacterium vaccae in patients with moderate to advanced pulmonary tuberculosis

Immunotherapy
Diana DlugovitzkyJohn Stanford

Abstract

A research investigation to evaluate the potential of an oral preparation of Mycobacterium vaccae SRL172 (NCTC 11659) as an immunotherapeutic has been carried out in ten patients with moderate to advanced pulmonary tuberculosis at Carrasco Hospital, Argentina. Comparison was made between oral and injected M.vaccae sharing a mutual control group. Clinical, bacteriological, hematological, radiological and immunological assessments all showed comparable benefits for both injected and oral treatment over those achieved with chemotherapy alone. The only significant difference between results of injected and oral M.vaccae was the failure of the latter to reduce TNF-alpha production by cultured mononuclear cells. A more intensive regime for the oral preparation was used, which as an addition to the directly observed therapy, short-course, treatment should improve results in both drug susceptible and drug-resistant cases. A Phase II Good Clinical Practice trial is now required.

References

Jun 1, 1974·Tubercle·J L Stanford, J M Grange
Jan 1, 1994·Annual Review of Immunology·P Matzinger
Jan 1, 1996·International Review of Cytology·A GebertR Pabst
Dec 30, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C F von ReynJ F Modlin
Jun 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R D WaddellC F von Reyn
Aug 30, 2001·Science Progress·J L StanfordJ M Grange
Jul 1, 1951·A.M.A. Archives of Internal Medicine·N I BERLINS PORT
Feb 24, 2004·Frontiers in Bioscience : a Journal and Virtual Library·John StanfordJohn Grange
Jul 21, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mohamed Abdel Aziz, Abigail Wright
Apr 21, 2007·Tropical Medicine & International Health : TM & IH·Mukund Uplekar, Knut Lönnroth
May 17, 2007·Current Molecular Medicine·Graham A W Rook
Jul 20, 2007·Bulletin of the World Health Organization·Mario C Raviglione
Oct 12, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J L StanfordJ M Grange
Jan 1, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P M PatelP J Selby
Feb 13, 2009·Neuroimmunomodulation·Oscar BottassoAdriana del Rey
Apr 10, 2009·Current Pharmaceutical Design·John StanfordJohn Grange
Nov 21, 2009·Clinics in Chest Medicine·Gavin J ChurchyardGraham A Rook
Dec 2, 2009·International Journal of STD & AIDS·S Reid, A A Van Niekerk

❮ Previous
Next ❯

Citations

Mar 9, 2012·Expert Review of Anti-infective Therapy·Aldar S BourinbaiarGalyna A Kutsyna
Jan 5, 2011·Clinical & Developmental Immunology·Carlos Rodrigo Zárate-BladésGeraldo A Passos
Nov 6, 2013·Transboundary and Emerging Diseases·B M BuddleA Heiser
Jun 21, 2013·Human Vaccines & Immunotherapeutics·Yuri V EfremenkoAldar S Bourinbaiar
Jan 18, 2013·Human Vaccines & Immunotherapeutics·Carlos R Zárate-BladésCelio L Silva
Mar 1, 2012·International Journal of Mycobacteriology·John Stanford, Cynthia Stanford
Apr 15, 2014·Vaccine·Matthias I GröschelTjip S van der Werf
Mar 27, 2018·Expert Review of Respiratory Medicine·Octavio Ramos-EspinosaRogelio Hernández-Pando
Mar 19, 2014·Journal of Internal Medicine·J Weiner, S H E Kaufmann

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

Cell Quest

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.